Saturday, May 24, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Updates: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Sat, 24 May 2008 12:03:37 -0500 (CDT)
Subject: CDER New 5/22 & 23/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

May 23, 2008

May 22, 2008

  • New and Generic Drug Approvals
    • Biaxin (clarithromycin) Tablets, Abbott Laboratories, Labeling Revision
    • Biaxin (clarithromycin) Oral Suspension, Abbott Laboratories, Labeling Revision
    • Biaxin XL (clarithromycin) Extended-Release Tablets, Abbott Laboratories, Labeling Revision
    • Keflex (cephalexin) Capsules, Lex Pharmaceuticals, Inc., Labeling Revision
    • Noxafil (posaconazole) Oral Suspension, Schering Corp., Labeling Revision


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420